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+A: Abstract 
Objectives The postmortem fetal brain:liver weight ratio is commonly used as a marker 
of nutrition for diagnosis of fetal growth restriction (FGR), but this is based on limited 
data. Additionally, there are limited data regarding the effects of intrauterine retention, 
fetal maceration and postmortem interval on organ weights and their ratios at autopsy. 
Our aims were to examine the relationships between gestational-age-adjusted and sex-
adjusted fetal organ weights at autopsy, maternal factors, cause of intrauterine death and 
effects of intrauterine retention, and to determine whether brain:liver weight ratio is a 
reliable marker of FGR in fetal deaths. 
Methods As part of a larger study examining autopsy findings in intrauterine death, 
data from two specialist centers in London was collated in a specially designed 
database. Autopsy and clinical information for > 1000 intrauterine deaths between 2005 
and 2013 were extracted. Adjusted (delta) organ weights were calculated by plotting 
against gestational age, female and male brain, liver, thymus, heart, combined kidney, 
combined lung, spleen and combined adrenal gland weights. Polynomial regression was 
used to determine best fit and to calculate expected (50th centile) organ weights and 
deviations from expected. We compared adjusted organ weights and body:organ weight 
ratios in fetuses which were small-for-gestational-age (SGA) at autopsy (birthweight 
<10th centile for normal livebirths) versus those which were not, and in macerated vs 
non-macerated fetuses. 
Results The majority of fetal organs (brain, liver, heart, thymus, lungs, kidneys and 
thyroid) in SGA fetuses were significantly lighter than those of non-SGA fetuses. 
Body:organ weight ratios for thymus, liver and spleen were significantly greater in SGA 
fetuses, indicating these organs being disproportionately small. The majority of organs 
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were significantly lighter in macerated compared with non-macerated fetuses and 
body:organ weight ratios for most organs (liver, thymus, lung, pancreas, adrenal gland, 
kidney, heart) were significantly greater in macerated compared with non-macerated 
fetuses. When SGA cases with demonstrable placental histological abnormalities 
werecompared to other SGA cases, there was a significant difference in the brain:liver 
weight ratio (median, 6 vs 3). 
Conclusion Changes after intrauterine death lead to loss of fetal weight, with 
preferential weight loss of visceral organs such as liver. Maceration therefore affects 
brain:liver weight ratio and such changes should be adjusted for during interpretation of 
such ratios. Fetal organ weights may be affected significantly by maternal factors, 
mechanism of death and postmortem changes. The fetal brain:liver weight ratio may 
provide useful information regarding intrauterine growth status at time of death, 
providing that  adjustment is made for effects of intrauterine retention and that 
appropriate cut-off values are used. 
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+A: Introduction 
The guidelines of the Royal College of Pathologists regarding autopsy in stillborn 
infants  recommend the weighing of all organs1. There are limited published data 
regarding the effects of maternal factors on fetal organ weights, which is somewhat 
surprising since factors such as body mass index and ethnicity are associated with 
stillbirth2–5. Intrauterine fetal growth restriction (FGR) has been suggested as a possible 
important contributor to stillbirth3,6–8, but there are difficulties in establishing this 
diagnosis after death9, since small-for-gestational age (SGA) with weight below a given 
centile of the normal range is not analogous to FGR10.  
There are few published studies examining the effects of cause of death in 
stillbirth on organ weights and hence the potential usefulness of organ weight metrics 
for determining cause or mode of death. Postmortem brain:liver weight ratio is 
commonly used as a marker of nutrition in fetuses for diagnosis of FGR, but this is 
based on limited, historical data with littleinformation regarding effects of intrauterine 
retention, fetal maceration and postmortem interval on brain:liver weight ratio11–13.  
The aims of this study were, therefore, to examine whether there are significant 
relationships between gestational-age-adjusted and sex-adjusted fetal organ weights at 
autopsy, and maternal factors, cause of intrauterine death and changes due to 
intrauterine retention, and to determine whether brain:liver weight ratio is a reliable 
marker of FGR as the cause of fetal death.  
.  
 
+A: Methods 
As part of a larger study examining several aspects of autopsy findings in intrauterine 
death, detailed data from > 1000 autopsies for investigation of intrauterine fetal death 
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(IUFD) from two specialist centers in London (Great Ormond Street Hospital and St 
George’s Hospital) were collated and entered into a specially designed Microsoft 
Access Autopsy Database (Microsoft Corp., Redmond, WA, USA). More than 400 data 
fields were included for each case, with criteria defined objectively prior to 
commencement of the study to ensure data consistency.  
For the purposes of this study, we extracted information including autopsy and antenatal 
details from all IUFDs (excluding terminations) between 2005 and 2013 inclusive. Fetal 
body weight and organ weights were identified and data were analyzed through queries 
and statistical tests run using Microsoft Access and Microsoft Excel (Microsoft Corp.), 
GraphPad Prism (GraphPad Software Inc., San Diego, CA, USA) and Stats Direct 
(StatsDirect Ltd., Altrincham, UK). For calculation of adjusted (‘delta’) organ weights, 
female and male fetal organ weights were plotted separately against gestational age, and 
polynomial regression calculations were used to determine best fit and to calculate 
expected (50th centile) organ weights for sex and gestation. The regression equation was 
interpolated to determine the 2.5th centile for gestation and the SD in grams for each 
gestational age was calculated as: (50th centile value – 2.5th centile value)/1.96. Delta 
values for each organ were calculated as: (observed organ weight – expected organ 
weight)/SD, allowing comparison of organ weights between different clinical groups, 
adjusting for the effects of gestational age and fetal sex. Raw values were used for ratio 
calculations.Body:organ weight ratios were calculated for all major organs and 
brain:liver and brain:thymus ratios calculated since these have been previously 
suggested as possible markers of FGR. For consistency with the existing literature, SGA 
was defined as birth weight < 10th centile of the expected normal range for fetal sex and 
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gestational age (using World Health Organization reference range > 23 weeks of 
gestation). Cause of death was assigned according to predefined objective criteria. 
+A: Results 
 
There were 1064 autopsies for investigation of IUFDdelivered across the second and 
third trimesters. Data on organ weights and gestational age at delivery were available 
for 911 brains, 957 livers, 930 thymuses, 967 hearts, 913 spleens, 952  adrenals 
(combined weight), 313 lungs (combined weight), 406 kidneys (combined weight), 745 
pancreas’ and 154 thyroids. The relationships between organ weights and gestational 
age for the major organs are shown in Figure 1.  Based on weights adjusted for 
gestational age and fetal sex (delta organ weight), the majority of organs (brain, liver, 
heart, thymus, lungs, kidneys and thyroid) in SGA fetuses were significantly lighter 
than those in non-SGA fetuses (P < 0.0001, P < 0.0001, P < 0.0001, P < 0.0001, 
P < 0.0001, P < 0.0001, P = 0.03 respectively). The liver and thymus were significantly 
lighter in cases with a placental cause of death (defined here as abruption, antenatally 
diagnosed FGR, pre-eclampsia and definite placental parenchymal abnormalities) 
compared with cases of unexplained death (P < 0.0001 and P = 0.01, respectively).  
Body:organ weight ratios for the thymus, liver and spleen were significantly 
greater in cases of SGA compared with non-SGA fetuses (P < 0.001 for all) indicating 
that the thymus, liver and spleen were disproportionately small. The brain:thymus 
weight ratio was significantly greater in SGA fetuses (P < 0.0001) indicating that the 
thymus was also disproportionately lighter than the brain.    
The majority of organs (brain, liver, thymus, heart, lungs, adrenals, and thyroid) 
were significantly lighter in macerated compared with non-macerated fetuses (P < 0.01 
for all). Furthermore, body:organ weight ratios for most organs (liver, thymus, lung, 
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pancreas, adrenal gland, kidney, heart) were significantly greater in macerated 
compared with non-macerated fetuses (P < 0.01 for all), demonstrating that macerated 
fetuses had disproportionately lighter organs compared with body weight, i.e. that 
internal organs lose weight more than do the musculoskeletal elements of the body 
during the period of intrauterine retention following intrauterine death. Similarly, the 
brain:liver weight ratio  was significantly greater in macerated compared with non-
macerated fetuses (P < 0.0001; median (range), 3.94 (0.09–9.97) vs 2.78 (1.17–9.95); 
median difference, 1.08 (95% CI, 0.90–1.27)), demonstrating preferential loss of liver 
compared to brain weight after intrauterine death with retention. The brain:liver weight 
ratio remained significantly greater even when only unexplained deaths were evaluated 
(P < 0.0001; median (range), 3.84 (0.09–9.88) vs 3.05 (1.47–9.95); median difference, 
0.77 (95% CI, 0.52–1.04)). In retained (macerated) IUFDs the brain:liver weight ratio 
should therefore be adjusted by 0.8–1 to take into account secondary effects of 
maceration (Figure 2). 
The brain:liver weight ratio was significantly greater in SGA fetuses compared 
with non-SGA fetuses (P < 0.0001; median (range), 4.84 (0.51–9.88) vs 3.42 (1.32–
8.92); median difference, 1.38 (95% CI, 1.03–1.72; Figure 3)), indicating that SGA 
fetuses have a disproportionally lighter liver in relation to brain weight suggesting that 
the liver disproportionately fails to gain weight more  than the brain in SGA. However, 
when SGA cases were separated into cases FGR with placentalFGR-associated 
placental pathology ( abruption, pre-eclampsia, maternal vascular malperfusion), and 
compared with those without such placental changes, there was a significant difference 
in their brain:liver weight ratio (P < 0.0001; median (range), 6.03 (0.51–10.00) vs 4.27 
(1.17–9.88); median difference, 1.55 (95% CI, 0.86–2.21)), indicating that 
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‘pathological’ SGA due to FGR with placental pathology is associated with 
disproportionally lighter livers in relation to brain weight compared with SGA cases 
without placental abnormalities,  distinguishing pathological FGR from ‘normal, small’ 
SGA cases.  
A brain:liver weight ratio of 6 differentiated placental FGR from SGA without 
significant placental pathology, withsensitivity of 53% and specificity of 80% (Figure 
4a), and would identify SGA with placental disease versus all other causes of death with 
sensitivity of 55% and specificity of 92% (Figure 4b). However, tehre was no 
brain:liver weight ratio that absolutely distinguished these groups; some cases of 
‘placental FGR’ had a brain:liver ratio of 2–3, whilst some cases with no evidence of 
placental disease or other pathology had ratios > 6. However, cases with birth 
weight > 10th centile without placental pathological lesions only rarely had brain:liver 
weight ratio above 6 and the brain:liver weight ratio remained significantly greater in 
cases of placental cause of death compared with other causes, regardless of bodyweight 
centile (P < 0.0001; median (range), 6.10 (0.51–10.00) vs 3.59 (1.17–9.88); median 
difference, 2.38 (95% CI, 1.83–2.94)). 
 
+A: Discussion 
The findings of this large study highlight several issues regarding the use of organ 
weight assessment at autopsy for diagnosis of FGR in IUFD. First, changes with 
intrauterine retention after death, such as maceration, lead to loss of fetal weight, with 
preferential weight loss of visceral organs, such as the liver, compared with the body. 
Second, maceration affects organ weights differentially and hence affects their ratios, 
for example the brain:liver weight ratio. Such changes should be adjusted for during 
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interpretation.. Third, the brain:liver weight ratio in non-SGA fetuses has a median 
normal value of around 2.5–3 but the normal range extends to 5. Finally, the brain:liver 
weight ratio can be used to distinguish non-FGR-SGA from FGR, and stillbirths with 
placental pathologies from other causes of death, with a ratio of 6 providing optimal 
sensitivity and specificity. However, there is no ratio value that identifies FGR 
unequivocally.  
Most organs were significantly lighter in SGA compared with non-SGA fetuses 
and even after adjusting for body weight organs such as the liver and thymus were 
disproportionately lighter, with preferential visceral organ weight loss with maceration. 
Furthermore, the liver and thymus were disproportionately lighter in cases with a 
placental cause of death even after accounting for the reduction in fetal body weight. 
One previous study has reported reduction in weights of visceral organs with increasing 
maceration, but did not provide data on organ weight ratios or mechanisms of death15. 
Previous data based on smaller, less-defined datasets have suggested a 
relationship between SGA, FGR and fetal brain:liver weight ratio.9-11 Despite these 
studies themselves reporting that the feature is crude and performs poorly9, the use of a 
brain:liver weight ratio of above 3–3.5 being indicative of FGR has entered the pediatric 
pathology literature9,11,13. However, these studies included heterogeneous populations, 
did not strictly separate pathological FGR versus SGA and did not account for effects of 
intrauterine retention, all of which we are addressed here.. Previous fetal brain:liver 
weight ratio data is from a first  study of 95 mixed stillbirths and neonatal deaths from 
more than 40 years ago13. The average ratio in those with a birth weight of 1SD above 
the mean was three in gestations > 27 weeks, a finding similar to the present data, with 
SGA cases having an increased ratio. The second study was from 2001, in which the 
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brain:liver weight ratio was examined in 182 stillbirths11. Growth restriction was based 
on body weight < 10th centile and it was reported that SGA fetuses had significantly 
greater ratios compared with controls11. It was also stated that there was marked overlap 
between the SGA and control groups.  
The current data therefore confirm an association between increased brain:liver 
weight ratio and SGA, and furthermore demonstrate that this increase is due to those 
with pathological FGR with placental disease, which affects around half of apparent 
SGA cases. This dataset also provides the normal range in a large series of intrauterine 
deaths. The findings indicate that a brain:liver weight ratio ≥ 6 provides a clinically 
useful marker with which to distinguish pathological FGR from non FGR small fetuses 
and from other causes of death, the latterwith specificity of 92% and a sensitivity of 
55%. Furthermore, it is possible to differentiate pathological FGR with concurrent 
placental abnormalities and placental cause of death from cases with biometry below 
the 10th centile but with no placental abnormalities using a brain:liver weight ratio of 6, 
with specificity 80% and sensitivity 53%. Following intrauterine death with retention 
and maceration, use of an unadjusted brain:liver weight ratio will erroneously 
overestimate the frequency of pathological FGR, since the liver loses weight 
disproportionately to the brain; in the presence of maceration the brain:liver weight ratio 
should be adjusted by a value of around 1.  
Given that the brain:liver weight ratio appears to provide useful information 
regarding mechanism of death, it remains undetermined whether such information could 
be obtained non-invasively. Data are available evaluating postmortem magnetic 
resonance imaging (MRI) measurement of fetal organ volumes compared with standard 
autopsy organ weights, but with small numbers of cases at present; an MRI study 
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including 25 perinatal deaths at 16–40 weeks’ gestation, in which MRI was performed 
prior to autopsy, reported a linear relationship between MRI organ volume estimates 
and autopsy organ weights16. These preliminary data suggest that postmortem MRI may 
have the potential to replace invasive autopsy measurements of brain:liver weight ratio, 
but further, larger studies are needed.   
The strengths of the current study include the use of a large dataset (at least five 
times larger than that of the previous largest study11) and use of predefined criteria for 
classification and recording of variables. Furthermore, this is the first study to evaluate 
pathologically determined mechanisms in SGA fetuses rather than using weight < 10th 
centile as an ‘outcome’. Finally, the study design allowed evaluation of the effects of 
confounding factors, such as maceration and intrauterine retention, on the brain:liver 
weight ratio. Potential weaknesses include those associated with use of a retrospective 
dataset derived from routine clinical measurements. For example, there was no 
evaluation of scale calibration. This is, however minimized by using only cases from 
Clinical Pathology Accreditation -approved centers, in which appropriate quality 
assurance structures are in place, working to established standards. Finally, these data 
demonstrate an association between organ weight ratios, mainly the brain:liver weight 
ratio, and placental findings, but do not in themselves provide evidence that FGR was 
the cause of death, merely indicating that it was present.  
In conclusion, fetal organ weight ratios, such as the brain:liver weight ratio, may 
provide important information regarding fetal intrauterine growth status at autopsy, 
provided that appropriate adjustment is made for the effects of intrauterine retention and 
maceration, and that appropriate cut-off values are used.  
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Figure 1 Scatterplots with polynomial regression lines for relationship between 
gestational age at intrauterine death across the second and third trimesters and fetal 
organ weight at postmortem in a series of intrauterine deaths: (a) brain, (b) liver, (c) 
thymus, (d) heart, (e) combined kidneys, (f) combined lungs, (g) spleen and (h) 
combined adrenal glands. 
 
Figure 2 Distribution of brain:liver weight ratio in a series of intrauterine deaths, 
according to whether there was maceration (------) or no maceration (––––) at 
postmortem. With intrauterine death, retention and maceration, the fetal liver loses 
weight disproportionately relative to the brain and the curve shifts to the right. 
 
Figure 3 Distribution of brain:liver weight ratio in a series of intrauterine deaths, 
according to whether they were appropriate-for-gestational age with an unexplained 
cause of death (______; median value, 3), small-for-gestational age (SGA)  
with a placental cause of death, i.e. growth-restricted (-----; median value, 6) or SGA 
with no placental pathology (……..; median value, 3). The three groups had significantly 
different brain:liver weight ratio distributions (P<0.0001).  
 
 
Figure 4 Receiver–operating characteristic curves of brain:liver weight ratio for cases 
or ‘fetal growth restriction with placental pathology versus other SGA cases (a) and 
versus all other causes of death (both SGA and non-SGA) (b), based on a brain:liver 
weight ratio of 6. 
 
